People struggling with many addictions, ranging from opioids to gambling, are reporting similar experiences in clinics, on ...

A large study found that people taking GLP-1 drugs like Ozempic for diabetes were less likely to be diagnosed with substance use disorder.

TEACHER OF THE YEAR COMPETITION. CONGRATULATIONS TO HER, AND WE WANT TO INVITE YOU TO JOIN US LATER THIS MONTH FOR WYFF NEWS FOUR’S LATEST HOUR LONG SPECIAL, CHRONICLE STATE OF ADDICTION. WE’LL ...

Evidence is mounting that the wildly popular weight-loss medicines known as GLP-1s may also hold potential for treating addiction, and the field may be on the verge of obtaining desperately needed ...

A new study found GLP-1 drugs were associated with 50% fewer substance-related deaths, 39% fewer drug overdoses, and 26% ...

A large study of data from Veterans Affairs finds that people on GLP-1 drugs were less likely to develop substance abuse disorder or overdose.

Research suggests the drugs have potential for prevention and harm reduction in substance use disorders, writes Ziyad Al-Aly People taking glucagon-like peptide-1 (GLP-1) receptor agonists often ...

A class of medications best known for treating diabetes and obesity may also reduce the risk of addiction—and help people who already have one, a new study shows.

People often joke that their favorite snack is "like crack" or call themselves "chocoholics" in jest. But can someone really be addicted to food in the same way they could be hooked on substances such ...

Since weight-loss drugs that target the hormone GLP-1 have surged in popularity, some additional health benefits have emerged. Beyond helping people shed pounds, they also lower the risk of heart ...